Cargando…

Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions

BACKGROUND/AIMS: Disrupted bile acid regulation and accumulation in the liver can contribute to progressive liver damage and fibrosis. However, the effects of bile acids on the activation of hepatic stellate cells (HSCs) remain unclear. This study investigated the effects of bile acids on HSC activa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jing, Tang, Xujiao, Liang, Zhu, Chen, Mingzhu, Sun, Lixin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121313/ https://www.ncbi.nlm.nih.gov/pubmed/36800698 http://dx.doi.org/10.3350/cmh.2022.0327

Ejemplares similares

Inhibition of canalicular and sinusoidal taurocholate efflux by cholestatic drugs in human hepatoma HepaRG cells
por: Le Vée, Marc, et al.
Publicado: (2022)

Lipopolysaccharide Inhibits Autophagy and Promotes Inflammatory Responses via p38 MAPK-Induced Proteasomal Degradation of Atg13 in Hepatic Stellate Cells
por: Wu, Yuchao, et al.
Publicado: (2022)

GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation
por: Kostadinova, Radina, et al.
Publicado: (2012)

Myocardin‐related transcription factor A drives ROS‐fueled expansion of hepatic stellate cells by regulating p38‐MAPK signalling
por: Dong, Wenhui, et al.
Publicado: (2022)

Cholangiocyte-Derived Exosomal lncRNA H19 Promotes Macrophage Activation and Hepatic Inflammation under Cholestatic Conditions
por: Li, Xiaojiaoyang, et al.
Publicado: (2020)

Cholestatic hepatitis with intravenous ceftriaxone
por: Kaur, Inderpal, et al.
Publicado: (2011)

Azathioprine induced cholestatic hepatitis
por: Moses, Viju, et al.
Publicado: (2011)

Azithromycin-induced cholestatic hepatitis
por: Koffas, Apostolos, et al.
Publicado: (2017)

Roseotoxin B alleviates cholestatic liver fibrosis through inhibiting PDGF-B/PDGFR-β pathway in hepatic stellate cells
por: Wang, Xingqi, et al.
Publicado: (2020)

YAP Activation Drives Liver Regeneration after Cholestatic Damage Induced by Rbpj Deletion
por: Tharehalli, Umesh, et al.
Publicado: (2018)

Targeting Mechanosensitive Piezo1 Alleviated Renal Fibrosis Through p38MAPK-YAP Pathway
por: Fu, Yuanyuan, et al.
Publicado: (2021)

Sodium Taurocholate Micelles in Fluorometrix Analysis
por: McGown, Linda B., et al.
Publicado: (1988)

Hepatic Expression of the Na(+)-Taurocholate Cotransporting Polypeptide Is Independent from Genetic Variation
por: Tremmel, Roman, et al.
Publicado: (2022)

Cholestatic hepatitis due to Salmonella typhi
por: Albayrak, Ayse, et al.
Publicado: (2011)

Echinacea-associated acute cholestatic hepatitis
por: Gabranis, I, et al.
Publicado: (2015)

Mechanisms of Hepatic Cholestatic Drug Injury
por: Kolarić, Tea Omanović, et al.
Publicado: (2019)

Knockout of α-calcitonin gene-related peptide attenuates cholestatic liver injury by differentially regulating cellular senescence of hepatic stellate cells and cholangiocytes
por: Wan, Ying, et al.
Publicado: (2019)

ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation
por: Zhang, Kun, et al.
Publicado: (2016)

PNPLA3 I148M Up-Regulates Hedgehog and Yap Signaling in Human Hepatic Stellate Cells
por: Bruschi, Francesca Virginia, et al.
Publicado: (2020)

Loss of TAZ after YAP deletion severely impairs foregut development and worsens cholestatic hepatocellular injury
por: Gabdulkhakova, Adelya, et al.
Publicado: (2023)

Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis
por: Ozkan, Tanju Basarir, et al.
Publicado: (2007)

Carbimazole-induced cholestatic hepatitis in Graves’ disease
por: Kota, Sunil K., et al.
Publicado: (2013)

Nafcillin-Induced Allergic Eosinophilic Cholestatic Hepatitis
por: Guido, Mark V., et al.
Publicado: (2017)

Giant Cell Arteritis Presenting as Cholestatic Hepatitis
por: Riordan, Gerald, et al.
Publicado: (2021)

Keratin 7 expression in hepatic cholestatic diseases
por: Sakellariou, S., et al.
Publicado: (2021)

Tozinameran: Severe cholestatic hepatitis: case report
Publicado: (2021)

ABCA8-mediated efflux of taurocholic acid contributes to gemcitabine insensitivity in human pancreatic cancer via the S1PR2-ERK pathway
por: Yang, Chunmei, et al.
Publicado: (2021)

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
por: Yan, Huan, et al.
Publicado: (2012)

Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide
por: He, Wenhui, et al.
Publicado: (2015)

Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes
por: Fukano, Kento, et al.
Publicado: (2019)

UM-164, a Dual Inhibitor of c-Src and p38 MAPK, Suppresses Proliferation of Glioma by Reducing YAP Activity
por: Xu, Huizhe, et al.
Publicado: (2022)

Calcipotriol Inhibits NLRP3 Signal Through YAP1 Activation to Alleviate Cholestatic Liver Injury and Fibrosis
por: Wang, Xiaopeng, et al.
Publicado: (2020)

Aging-Related Molecular Pathways in Chronic Cholestatic Conditions
por: Pinto, Claudio, et al.
Publicado: (2020)

Fibrosing cholestatic hepatitis: a report of three cases.
por: Lee, H. K., et al.
Publicado: (2000)

Cholestatic Hepatitis and Thrombocytosis in a Secondary Syphilis Patient
por: Kim, Gi Hyun, et al.
Publicado: (2010)

Cholestatic Hepatitis with Small Duct Injury Associated with Celecoxib
por: Nayudu, Suresh Kumar, et al.
Publicado: (2013)

Cholestatic Hepatitis in Graves' Disease: A Diagnostic Challenge
por: Haddaden, Metri, et al.
Publicado: (2021)

Epstein-Barr Virus Reactivation Causing Cholestatic Hepatitis
por: Da Cunha, Teresa, et al.
Publicado: (2022)

Salvianolic Acid B Inhibits ERK and p38 MAPK Signaling in TGF-β1-Stimulated Human Hepatic Stellate Cell Line (LX-2) via Distinct Pathways
por: Lv, Zhigang, et al.
Publicado: (2012)

12-O-tetradecanoylphorbol-13-acetate Reduces Activation of Hepatic Stellate Cells by Inhibiting the Hippo Pathway Transcriptional Coactivator YAP
por: Kim, Chang Wan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qv2qubp568ik5rejfaikbsjf0t